Variants in the SLCO1B3 gene:: Interethnic distribution and association with paclitaxel pharmacokinetics
Variants in the SLCO1B3 gene:: Interethnic distribution and association with paclitaxel pharmacokinetics
复制标题
DOI:
10.1038/sj.clpt.6100011
复制
发表时间:
2007-01-01
影响因子:
6.7
通讯作者:
Sparreboom, A.
中科院分区:
文献类型:
--
作者:
Smith, N. F.;Marsh, S.;Sparreboom, A.
To explore retrospectively the relationships between paclitaxel pharmacokinetics and three known, non-synonymous single-nucleotide polymorphisms (SNPs) in SLCO1B3, the gene encoding organic anion transporting polypeptide (OATP) 1B3. Accumulation of [H-3]paclitaxel was studied in Xenopus laevis oocytes injected with cRNA of Oatp1b2, OATP1A2, OATP1B1, OATP1B3, OAT1, OAT3, OCT1, and INITCP. The 334T > G (Ser112Ala), 699G > A (Met233lle), and 1564G > T (Gly522Cys) loci of SLCO1B3 were screened in 475 individuals from five ethnic groups and 90 European Caucasian cancer patients treated with paclitaxel. Only OATP1B3 was capable of transporting paclitaxel to a significant extent (P = 0.003). The 334T > G and 699G > A SNPs were less common in the Africa n-American and Ghanaian populations (P < 0.000001). Paclitaxel pharmacokinetics were riot associated with the studied SNPs or haplotypes (P > 0.3). The studied SNPs in SLCO1B3 appear to play a limited role in the disposition of paclitaxel, although their clinical significance in other ethnic populations remains to be investigated.